Wagner, J. Y., Schwarz, K., Schreiber, S., Schmidt, B., Wester, H., Schwaiger, M., . . . Keller, U. (2013). Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival. Impact Journals LLC.
Styl cytowania ChicagoWagner, Julia Y., et al. Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed By Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival. Impact Journals LLC, 2013.
Styl cytowania MLAWagner, Julia Y., et al. Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed By Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival. Impact Journals LLC, 2013.